论文部分内容阅读
由于动脉血栓摘除术技术上的困难及全身抗凝治疗所带来的出血等并发症限制了动脉血栓摘除术及全身抗凝疗法在临床上的应用。研究使用重组组织纤维蛋白酶活化剂（ｒＴＰＡ）治疗新生儿动脉血栓。对象和方法 １９９３～１９９５年７例新生儿动脉血栓患儿来自密执安大学。诊断
Due to the technical difficulties of arterial thrombectomy and complications such as bleeding caused by systemic anticoagulation, the clinical application of arterial thrombectomy and systemic anticoagulation therapy is limited. Study using recombinant tissue fibrinolytic activator (r TPA) treatment of neonatal arterial thrombosis. Subjects and methods From 1993 to 1995, seven neonates with arterial thrombosis were from the University of Michigan. diagnosis